Health-care companies were more or less flat as traders rotated into the defensive sector ahead of jobs data.

Over-the-counter drugs maker Kenvue, which was spun off by Johnson & Johnson, posted growth in second-quarter earnings and revenue.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

August 06, 2026 17:50 ET (21:50 GMT)